Myotube cell development

pathway activity — cross-omics
GO:0014904Cross-omicsRNA → PROTEIN-MSPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Myotube cell development pathway is significantly associated with the protein abundance of multiple proteins, with the BRCA cohort showing a particularly strong set of associations.

The most reproducible pathway-associated proteins across cancer lineages are KANK2, SRRM2_S1320, and TNS2_S102, each associated with the pathway in up to 5 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Myotube cell development activity versus KANK2 in BRCA (Pearson r = 0.26).

Pathway-associated proteins by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner proteinX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BRCAKANK2 →+0.366+0.027.002<.00135
HNSCSRRM2_S1320 →-0.201-0.054<.001.00135
GBMTNS2_S102 →+0.400+0.036<.001.00435
GBMTRIM28_S697 →-0.858-0.049<.001<.00135
BRCARSU1 →+0.369+0.032<.001<.00134
BRCASH3BGRL2 →+0.462+0.023<.001.00634
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0014904 vs KANK2 — BRCA

Per-sample scatter of Myotube cell development activity vs KANK2 in BRCA.

Explore this scatter interactively →

Exploration